Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Bijal Shah; Ryan J Mattison; Ramzi Abboud; Peter Abdelmessieh; Ibrahim Aldoss; Patrick W Burke; Daniel J DeAngelo; Shira Dinner; Amir T Fathi; Jordan Gauthier; Michael Haddadin; Nitin Jain; Brian Jonas; Suzanne Kirby; Michaela Liedtke; Mark Litzow; Aaron Logan; Meixiao Long; Selina Luger; James K Mangan; Stephanie Massaro; William May; Olalekan Oluwole; Jae Park; Amanda Przespolewski; Sravanti Rangaraju; Caner Saygin; Marc Schwartz; Paul Shami; Benjamin Tomlinson; Jonathan Webster; Ajibola Awotiwon; Katie Stehman

doi:10.6004/jnccn.2024.0051

Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Bijal Shah, Ryan J Mattison, Ramzi Abboud, Peter Abdelmessieh, Ibrahim Aldoss, Patrick W Burke, Daniel J DeAngelo, Shira Dinner, Amir T Fathi, Jordan Gauthier, Michael Haddadin, Nitin Jain, Brian Jonas, Suzanne Kirby, Michaela Liedtke, Mark Litzow, Aaron Logan, Meixiao Long, Selina Luger, James K ManganStephanie Massaro, William May, Olalekan Oluwole, Jae Park, Amanda Przespolewski, Sravanti Rangaraju, Caner Saygin, Marc Schwartz, Paul Shami, Benjamin Tomlinson, Jonathan Webster, Ajibola Awotiwon, Katie Stehman

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. This selection from the NCCN Guidelines for ALL focuses on treatment recommendations for adults with newly diagnosed Ph-negative ALL based on current evidence.

Original language	English
Pages (from-to)	563-576
Number of pages	14
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	22
Issue number	8
DOIs	https://doi.org/10.6004/jnccn.2024.0051
State	Published - Oct 2024

Keywords

Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy
Medical Oncology/standards
Adult
Philadelphia Chromosome
Adolescent

Access to Document

10.6004/jnccn.2024.0051

Cite this

Shah, B., Mattison, R. J., Abboud, R., Abdelmessieh, P., Aldoss, I., Burke, P. W., DeAngelo, D. J., Dinner, S., Fathi, A. T., Gauthier, J., Haddadin, M., Jain, N., Jonas, B., Kirby, S., Liedtke, M., Litzow, M., Logan, A., Long, M., Luger, S., ... Stehman, K. (2024). Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 22(8), 563-576. https://doi.org/10.6004/jnccn.2024.0051

@article{4ff74d2858ff4000a83ab4516247cf9e,

title = "Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology",

abstract = "The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. This selection from the NCCN Guidelines for ALL focuses on treatment recommendations for adults with newly diagnosed Ph-negative ALL based on current evidence.",

keywords = "Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy, Medical Oncology/standards, Adult, Philadelphia Chromosome, Adolescent",

author = "Bijal Shah and Mattison, {Ryan J} and Ramzi Abboud and Peter Abdelmessieh and Ibrahim Aldoss and Burke, {Patrick W} and DeAngelo, {Daniel J} and Shira Dinner and Fathi, {Amir T} and Jordan Gauthier and Michael Haddadin and Nitin Jain and Brian Jonas and Suzanne Kirby and Michaela Liedtke and Mark Litzow and Aaron Logan and Meixiao Long and Selina Luger and Mangan, {James K} and Stephanie Massaro and William May and Olalekan Oluwole and Jae Park and Amanda Przespolewski and Sravanti Rangaraju and Caner Saygin and Marc Schwartz and Paul Shami and Benjamin Tomlinson and Jonathan Webster and Ajibola Awotiwon and Katie Stehman",

note = "Publisher Copyright: {\textcopyright} JNCCN.",

year = "2024",

month = oct,

doi = "10.6004/jnccn.2024.0051",

language = "English",

volume = "22",

pages = "563--576",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "8",

}

Shah, B, Mattison, RJ, Abboud, R, Abdelmessieh, P, Aldoss, I, Burke, PW, DeAngelo, DJ, Dinner, S, Fathi, AT, Gauthier, J, Haddadin, M, Jain, N, Jonas, B, Kirby, S, Liedtke, M, Litzow, M, Logan, A, Long, M, Luger, S, Mangan, JK, Massaro, S, May, W, Oluwole, O, Park, J, Przespolewski, A, Rangaraju, S, Saygin, C, Schwartz, M, Shami, P, Tomlinson, B, Webster, J, Awotiwon, A & Stehman, K 2024, 'Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 22, no. 8, pp. 563-576. https://doi.org/10.6004/jnccn.2024.0051

TY - JOUR

T1 - Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

AU - Shah, Bijal

AU - Mattison, Ryan J

AU - Abboud, Ramzi

AU - Abdelmessieh, Peter

AU - Aldoss, Ibrahim

AU - Burke, Patrick W

AU - DeAngelo, Daniel J

AU - Dinner, Shira

AU - Fathi, Amir T

AU - Gauthier, Jordan

AU - Haddadin, Michael

AU - Jain, Nitin

AU - Jonas, Brian

AU - Kirby, Suzanne

AU - Liedtke, Michaela

AU - Litzow, Mark

AU - Logan, Aaron

AU - Long, Meixiao

AU - Luger, Selina

AU - Mangan, James K

AU - Massaro, Stephanie

AU - May, William

AU - Oluwole, Olalekan

AU - Park, Jae

AU - Przespolewski, Amanda

AU - Rangaraju, Sravanti

AU - Saygin, Caner

AU - Schwartz, Marc

AU - Shami, Paul

AU - Tomlinson, Benjamin

AU - Webster, Jonathan

AU - Awotiwon, Ajibola

AU - Stehman, Katie

PY - 2024/10

Y1 - 2024/10

N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. This selection from the NCCN Guidelines for ALL focuses on treatment recommendations for adults with newly diagnosed Ph-negative ALL based on current evidence.

AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. This selection from the NCCN Guidelines for ALL focuses on treatment recommendations for adults with newly diagnosed Ph-negative ALL based on current evidence.

KW - Humans

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma/therapy

KW - Medical Oncology/standards

KW - Adult

KW - Philadelphia Chromosome

KW - Adolescent

UR - http://www.scopus.com/inward/record.url?scp=85203643472&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2024.0051

DO - 10.6004/jnccn.2024.0051

M3 - Article

C2 - 39413812

SN - 1540-1405

VL - 22

SP - 563

EP - 576

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 8

ER -

Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this